technetium tc 99m sestamibi has been researched along with Multiple Myeloma in 62 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (12.90) | 18.2507 |
2000's | 41 (66.13) | 29.6817 |
2010's | 11 (17.74) | 24.3611 |
2020's | 2 (3.23) | 2.80 |
Authors | Studies |
---|---|
Amorim, BJ; Carvalheira, JBC; de Souza, CA; Delamain, MT; Etchebehere, ECSC; Lima, MCL; Lorand-Metze, I; Miranda, ECM; Mosci, C; Oliveira, GB; Pericole, FV; Ramos, CD; Santos, AO; Takahashi, MES | 1 |
Baghdadi, Y; Di Dea, MT; Moadel, RM; Travin, MI | 1 |
Bulzan, J; Byun, K; Revels, J | 1 |
Catalano, L; Cerchione, C; De Luca, S; Del Vecchio, S; Fonti, R; Pace, L; Pane, F; Salvatore, B; Salvatore, M | 1 |
Ghaedian, T; Haghighatafshar, M; Mortazavi, S | 1 |
Bhave, A; Lele, RD; Luthra, K | 1 |
Bhambhvani, P; Farag, AA; Hage, FG; Patel, H | 1 |
Bacovsky, J; Kaminek, M; Koranda, P; Myslivecek, M; Nekula, J; Scudla, V | 1 |
Beksac, M; Comenzo, RL; Dimopoulos, M; Durie, BG; Kumar, S; Lokhorst, H; Moulopoulos, LA; Niesvizky, R; Rajkumar, SV; Sezer, O; Siegel, D; Terpos, E; Tosi, P | 1 |
Chakraborty, K; Hamati, AK; Hammad, AN; Ismail, HM; Jenigiri, B; Smalligan, RD | 1 |
Baldini, L; Calori, R; Carletto, M; Castellani, M; Dellavedova, L; Gerundini, P; Longari, V; Soligo, D | 1 |
Carty, F; Murray, JG; Shortt, CP | 1 |
Bacovsky, J; Buriankova, E; Koranda, P; Minarik, J; Myslivecek, M; Pika, T; Scudla, V; Zapletalova, J | 1 |
Bacovský, J; Buriánková, E; Formánek, R; Koranda, P; Minarík, J; Myslivecek, M; Scudla, V; Zapletalová, J | 1 |
Bartel, T; Brown, TL; De Blanche, L; Jones-Jackson, LB; Walker, RC | 1 |
Gatta, G; Prisco, MR; Scialpi, M; Vaccaro, A | 1 |
De Renzo, A; De Rosa, G; Karadimitris, A; Notaro, R; Rotoli, B | 1 |
Cerino, M; Demaria, S; Eybalin, MC; Lette, J; Levasseur, A | 1 |
Ak, I; Aslan, V; Gülbaş, Z; Vardareli, E | 1 |
Alexandrakis, MG; Karkavitsas, N; Kyriakou, DS; Malliaraki, N; Passam, FH; Vlachonikolis, IG | 1 |
Akbunar, T; Alper, E; Demiray, M; Evrensel, T; Gurel, M; Ozkocaman, V | 1 |
Andretta, C; Annunziata, G; Catalano, L; Fonti, R; Pace, L; Rotoli, B | 1 |
Athanasoulis, T; Dimopoulos, MA; Koutsikos, J; Moulopoulos, LA; Tsiouris, S; Zerva, C | 1 |
Del Vecchio, S; Pace, L; Salvatore, M | 2 |
Blum, R; Hicks, RJ; Mileshkin, L; Patrikeos, A; Prince, HM; Seymour, JF | 1 |
Catalano, L; De Renzo, A; Del Vecchio, S; Fonti, R; Pace, L; Rotoli, B; Salvatore, M; Zannetti, A | 1 |
Anagnostopoulos, A; Athanasoulis, T; Dimopoulos, MA; Koutsikos, J; Passadi, M; Velidaki, A; Zerva, C | 1 |
Donahue, L; John, V; Margouleff, D; Patel, N; Talwar, A | 1 |
Bacovsky, J; Myslivecek, M; Nekula, J; Scudla, V; Vytrasová, M | 1 |
Alba, PR; Banzo, JB; Dourdil Sahún, MV; Martín, MG; Olave, P; Romero Colás, MS | 1 |
Andretta, C; Buonanno, MT; Catalano, L; De Rosa, G; Del Vecchio, S; Pace, L; Paone, G; Rotoli, B; Salvatore, B | 1 |
Andretta, C; Catalano, L; De Renzo, A; Del Vecchio, S; Di Nuzzo, C; Fonti, R; Pace, L; Rotoli, B; Salvatore, B; Salvatore, M | 1 |
Balleari, E; Carletto, M; Clavio, M; Ghio, R; Gobbi, M; Grosso, M; Morbelli, S; Peschiera, F; Piccardo, A; Rebella, L; Tommasi, L; Villa, G | 1 |
Agostini, V; Ascoli, G; Berbellini, A; Brianzoni, E; Brunori, M; Cambioli, F; Catarini, M; Corvatta, L; Gradari, M; Isidori, A; Leoni, P; Marconi, M; Mele, A; Nonni, M; Offidani, M; Spinelli, A; Visani, G | 1 |
Califano, C; Caparrotti, G; Catalano, L; Del Vecchio, S; Fonti, R; Martorelli, C; Pace, L; Petruzziello, F; Rotoli, B; Salvatore, B; Segreto, S | 1 |
Abildgaard, N; D'Sa, S; Hall-Craggs, M; Shaw, P; Tighe, J | 1 |
Bakir, B; Berberoglu, K; Besisik, SK; Erten, N; Saka, B; Turkmen, C; Unal, S; Yekeler, E | 1 |
Catalano, L; Del Vecchio, S; Fonti, R; Liuzzi, R; Pace, L; Petruzziello, F; Quarantelli, M; Rotoli, B; Salvatore, B; Salvatore, M; Segreto, S; Sirignano, C | 1 |
Chowdhury, FU; Scarsbrook, AF | 1 |
Cavalli, F; Ceriani, L; Delaloye, AB; Giovanella, L; Taborelli, M; Zucca, E | 1 |
Adams, BK; Fataar, A; Nizami, MA | 1 |
Fuerst, MM; Giles, FJ; Gupta, PK; Kusuanco, DA; Lawrence, GN; Lim, SW; Look, RM; Waxman, AD | 1 |
Biassoni, L; Britton, KE; Kaleva, N; Kouykin, V; Malpas, JS; Tirovola, EB | 1 |
el-Shirbiny, AM; Imbriaco, M; Larson, SM; Macapinlac, H; Michaeli, J; Yeung, H | 1 |
Califano, C; Catalano, L; De Renzo, A; Del Vecchio, S; Di Gennaro, F; Pace, L; Pinto, A; Rotoli, B; Salvatore, M | 1 |
Hasegawa, Y; Hashizume, T; Hiraoka, A; Maeda, T; Masaoka, T; Nakamura, H; Teshima, H; Wakasugi, S | 1 |
Catalano, L; de Renzo, A; del Vecchio, S; Di Gennaro, F; Pace, L; Pinto, AM; Rotoli, B; Salvatore, M | 1 |
Califano, C; Catalano, L; De Renzo, A; Del Vecchio, S; Di Gennaro, F; Fonti, R; Pace, L; Pinto, AM; Rotoli, B; Salvatore, M | 1 |
Cavanaugh, D; Fisher, C; Houpt, L; Howe, K; Kashlan, B; Longa, G; Stark, L; Vehec, A | 1 |
De Rosa, G; Del Vecchio, S; Pezzullo, L | 1 |
Califano, C; Catalano, L; De Renzo, A; Di Gennaro, F; Pace, L; Pinto, AM | 1 |
Agnese, G; Balleari, E; Carletto, M; Clavio, M; Ferrando, F; Garrè, S; Ghio, R; Ghirlanda, P; Gobbi, M; Mariani, G; Villa, G | 1 |
Cho, IH; Chun, KA; Hayashida, K; Hyun, MS; Lee, HW; Lee, KH; Won, KC | 1 |
Califano, C; Catalano, L; De Renzo, A; Del Vecchio, S; Di Gennaro, F; Fonti, R; Pace, L; Rotoli, B; Salvatore, M; Zannetti, A | 1 |
Borrelli, G; Califano, C; Catalano, L; De Renzo, A; Del Vecchio, S; Di Gennaro, F; Pace, L; Rotoli, B; Salvatore, M; Sica, G; Tedesco, N | 1 |
Alexandrakis, MG; Karkavitsas, N; Koukouraki, S; Kyriakou, DS; Passam, F | 1 |
Bettini, D; Fabris, P; Franzelin, F; Gebert, U; Mitterer, M; Osele, L; Svaldi, M; Tappa, C | 1 |
Blocklet, D; Feremans, W; Kentos, A; Schoutens, A | 1 |
Lin, WY; Wang, SJ | 1 |
Aktolun, C; Arslan, A; Berk, F; Demir, H; Erdincler, O; Hacihanefioglu, A; Isgoren, S | 1 |
Alexandrakis, MG; Christophoridou, AV; Karkavitsas, N; Kyriakou, DS; Malliaraki, N; Passam, FH | 1 |
6 review(s) available for technetium tc 99m sestamibi and Multiple Myeloma
Article | Year |
---|---|
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
Topics: Absorptiometry, Photon; Bone Neoplasms; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Paraproteinemias; Plasmacytoma; Positron-Emission Tomography; Prognosis; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2009 |
The role of whole-body imaging in the diagnosis, staging, and follow-up of multiple myeloma.
Topics: Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Imaging of multiple myeloma and related plasma cell dyscrasias.
Topics: Bone and Bones; Bone Marrow Neoplasms; Bone Neoplasms; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Paraproteinemias; POEMS Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
[New diagnostic imaging approaches in multiple myeloma].
Topics: Diagnostic Imaging; Humans; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2012 |
Multiple myeloma cured by conventional chemotherapy: a report and a review.
Topics: Adult; Bone and Bones; Humans; Male; Multiple Myeloma; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2002 |
Hyperparathyroidism accompanying multiple myeloma.
Topics: Adenoma; Aged; Female; Humans; Hypercalcemia; Hyperparathyroidism; Multiple Myeloma; Neoplasms, Multiple Primary; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
14 trial(s) available for technetium tc 99m sestamibi and Multiple Myeloma
Article | Year |
---|---|
Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
Topics: Antineoplastic Agents; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Treatment Outcome | 2008 |
Tc-99m MIBI scintigraphy in multiple myeloma: prognostic value of different Tc-99m MIBI uptake patterns.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Prognosis; Radionuclide Imaging; Survival Analysis; Technetium Tc 99m Sestamibi | 2010 |
Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Aged; Antigens, CD; Biomarkers; Bone Marrow; Female; Flow Cytometry; Humans; Male; Membrane Glycoproteins; Middle Aged; Multiple Myeloma; Neoplasm Invasiveness; Plasma Cells; Predictive Value of Tests; Proteoglycans; Radionuclide Imaging; Severity of Illness Index; Syndecan-1; Syndecans; Technetium Tc 99m Sestamibi | 2003 |
99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Bone Neoplasms; Female; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Whole-Body Counting | 2003 |
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow; Diagnostic Imaging; Drug Resistance, Multiple; Female; Humans; Male; Middle Aged; Multiple Myeloma; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2004 |
Scintigraphy using (99m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Disease Progression; Female; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma.
Topics: Antineoplastic Agents; Disease-Free Survival; Female; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Multiple Myeloma; Prognosis; Radioisotope Dilution Technique; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Treatment Outcome | 2005 |
Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radionuclide Imaging; Remission Induction; Stem Cell Transplantation; Technetium Tc 99m Sestamibi | 2005 |
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis.
Topics: Aged; Diphosphonates; Fluorodeoxyglucose F18; Humans; Jaw Diseases; Multiple Myeloma; Osteonecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2007 |
Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
Topics: Adult; Aged; beta 2-Microglobulin; Biomarkers; Bone Marrow; Female; Humans; Immunoglobulin M; L-Lactate Dehydrogenase; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2007 |
Different patterns of technetium-99m sestamibi uptake in multiple myeloma.
Topics: Antibodies, Monoclonal; Bone Marrow; Bone Marrow Neoplasms; Female; Humans; Injections, Intravenous; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Whole-Body Counting | 1998 |
Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Female; Humans; Male; Middle Aged; Multiple Myeloma; Plasmacytoma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
Topics: Aged; Autoradiography; Bone Marrow; Bone Marrow Cells; Female; Humans; Male; Middle Aged; Multiple Myeloma; Plasma Cells; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Whole-Body Counting | 2001 |
Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.
Topics: Aged; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Whole-Body Counting | 2001 |
42 other study(ies) available for technetium tc 99m sestamibi and Multiple Myeloma
Article | Year |
---|---|
99mTc-sestamibi SPECT/CT and 18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma.
Topics: Adult; Aged; Biological Transport; Diffusion; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2020 |
A potential artifact to consider when performing
Topics: Artifacts; Humans; Multiple Myeloma; Perfusion; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2022 |
Progression of Multiple Myeloma Detected on Cardiac Scintigraphy with 99mTc Sestamibi.
Topics: Aged; Heart; Humans; Incidental Findings; Male; Multiple Myeloma; Myocardial Perfusion Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2018 |
18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2015 |
Multiple Myeloma and Abdominal Aortic Aneurysm on Myocardial Perfusion Raw Images.
Topics: Aged; Aortic Aneurysm, Abdominal; Humans; Incidental Findings; Male; Multiple Myeloma; Myocardial Perfusion Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2015 |
Tc 99m Sestamibi Scanning in Multiple Myeloma--a New look with SPECT-CT.
Topics: Female; Follow-Up Studies; Humans; Male; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Plasmacytoma; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Remission Induction; Technetium Tc 99m Sestamibi | 2014 |
Incidental detection of abnormal
Topics: Aged; Humans; Male; Multiple Myeloma; Myocardial Perfusion Imaging; Radiopharmaceuticals; Rib Cage; Sternum; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2017 |
A bone to pick about chest pain.
Topics: Aged; Blood Protein Electrophoresis; Bone Marrow Examination; Chest Pain; Exercise Test; Humans; Male; Multiple Myeloma; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2009 |
The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi.
Topics: Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multiple Myeloma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2010 |
[18F-FDG PET/CT and 99mTc-MIBI scintigraphy in evaluation of patients with multiple myeloma and monoclonal gammopathy of unknown significance: comparison of methods].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2010 |
Serendipitous diagnosis of multiple myeloma during sestamibi myocardial perfusion imaging.
Topics: Aged; Bone Neoplasms; Diagnosis, Differential; Heart; Humans; Leukemia; Lymphoma; Male; Multiple Myeloma; Myocardial Infarction; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Whole-Body Counting | 2002 |
Urinary N-telopeptide levels in multiple myeloma patients, correlation with Tc-99m-sestaMIBI scintigraphy and other biochemical markers of disease activity.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Bone and Bones; Calcium; Collagen; Collagen Type I; Creatinine; Female; Humans; Immunoglobulin A; Immunoglobulin G; Logistic Models; Male; Middle Aged; Multiple Myeloma; Peptides; Radionuclide Imaging; Radiopharmaceuticals; Skull; Technetium Tc 99m Sestamibi; Time Factors | 2003 |
99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Marrow; Dexamethasone; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thalidomide; Tissue Distribution | 2003 |
Reverse of the differential uptake intensity of Tc-99m MIBI and Tc-99m V-DMSA by multiple myeloma lesions in response to therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dexamethasone; Doxorubicin; Humans; Male; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Skull; Succimer; Technetium Tc 99m Sestamibi; Tibia; Treatment Outcome; Vincristine | 2003 |
A new role for nuclear medicine in multiple myeloma.
Topics: Humans; Multiple Myeloma; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2003 |
A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Retrospective Studies; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2004 |
Technetium 99m sestamibi in multiple myeloma.
Topics: B-Lymphocytes; Disease Progression; Humans; Incidence; Multiple Myeloma; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; United States | 2005 |
Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi; Treatment Outcome | 2005 |
BaselinTc99-MIBI scanning predicts survival in multiple myeloma and helps to differentiate this disease from monoclonal gammopathy of unknown significance.
Topics: Diagnosis, Differential; Humans; Multiple Myeloma; Paraproteinemias; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi | 2005 |
Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma.
Topics: Aged; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Multiple Myeloma; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Marrow; C-Reactive Protein; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Invasiveness; Neoplasm Staging; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Treatment Outcome | 2007 |
Guidelines for the use of imaging in the management of myeloma.
Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed; Whole-Body Counting | 2007 |
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2008 |
Tc-99m sestamibi uptake mimicking parathyroid adenoma in a patient with primary hyperparathyroidism and occult multiple myeloma.
Topics: Aged, 80 and over; Female; Humans; Hyperparathyroidism, Primary; Multiple Myeloma; Parathyroid Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
Topics: Bone Marrow; Female; Humans; Karyotyping; Male; Multiple Myeloma; Paraproteinemias; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2008 |
Technetium-99m-sestamibi uptake in myeloma.
Topics: Female; Humans; Hyperplasia; Immunoglobulin kappa-Chains; Middle Aged; Multiple Myeloma; Parathyroid Glands; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1996 |
Technetium-99m sestamibi scanning in multiple myeloma stem cell transplantation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dexamethasone; Disease Progression; Hematopoietic Stem Cell Transplantation; Humans; Humerus; Male; Mitoxantrone; Multiple Myeloma; Osteolysis; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1996 |
The use of 99mTc-MIBI scanning in multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Contrast Media; False Negative Reactions; False Positive Reactions; Humans; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1996 |
Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma.
Topics: Aged; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 1997 |
Tc-99m MIBI localization in bone marrow: a marker of bone marrow malignancy.
Topics: Adult; Aged; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Plasmacytoma; Prospective Studies; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1998 |
Tc-99m sestamibi scintigraphy in multiple myeloma.
Topics: Adult; Aged; Bone and Bones; Bone Marrow Examination; Humans; Male; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Skull; Technetium Tc 99m Sestamibi; Whole-Body Counting | 1999 |
Incidental detection of skeletal uptake on sestamibi cardiac images in a patient with previously undiagnosed multiple myeloma.
Topics: Aged; Aged, 80 and over; Bone and Bones; Dipyridamole; Female; Heart; Heart Failure; Humans; Multiple Myeloma; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2000 |
Avid (67)Ga uptake in multiple myeloma relapsing after bone marrow transplant.
Topics: Adult; Bone and Bones; Bone Marrow Transplantation; Fatal Outcome; Gallium Radioisotopes; Humans; Male; Multiple Myeloma; Radionuclide Imaging; Recurrence; Technetium Tc 99m Sestamibi | 2000 |
Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma.
Topics: Adult; Aged; Diagnosis, Differential; Disease-Free Survival; Female; Humans; Male; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2000 |
Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2001 |
Comparison of Tc-99m sestamibi and TI-201 uptake in multiple myeloma.
Topics: Bone Marrow; Female; Humans; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes | 2001 |
Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Humans; Male; Middle Aged; Multiple Myeloma; Prospective Studies; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 2001 |
Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy and autologous stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multiple Myeloma; Postoperative Period; Radiography; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Transplantation, Autologous | 2001 |
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
Topics: Bone Marrow; Humans; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2001 |
Ga-67 scan findings in bone marrow involvement with plasmablastic myeloma and corresponding Tc-99m MIBI images.
Topics: Aged; Bone Marrow Neoplasms; Gallium Radioisotopes; Humans; Male; Multiple Myeloma; Muscle Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Whole-Body Counting | 2001 |
Hepatic and splenic uptake of Tc-99m HDP in multiple myeloma: additional findings on Tc-99m MIBI and Tc-99m sulfur colloid images.
Topics: Bone and Bones; Humans; Liver; Male; Middle Aged; Multiple Myeloma; Radiopharmaceuticals; Spleen; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Technetium Tc 99m Sulfur Colloid; Tomography, Emission-Computed, Single-Photon | 2002 |
Correlation between the uptake of Tc-99m-sestaMIBI and prognostic factors in patients with multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Humans; Male; Middle Aged; Multiple Myeloma; Osteolysis; Prognosis; Statistics, Nonparametric; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2002 |